Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment

Cell Reports(2020)10.1016/j.celrep.2020.107884Source: DataRank Database

Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 36 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access36 citations

Download PDF

Cite:

Linked data & code

geo gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.44)OA: goldTopics (65)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Jiao Yuan ORCID,Zhongyi Hu ORCID,Junjie Jiang ORCID,Yueying Wang ORCID,Nicki Loo

Live enrichment

PubMed:32668240 PMC:PMC7391471 OpenAlex:https://openalex.org/W3042842519

National Institutes of Health

Grant: R01CA190415

National Institutes of Health

Grant: R01CA225929

National Institutes of Health

Grant: R01CA142776

National Institutes of Health

Grant: P50CA083638

National Institutes of Health

Grant: P50CA174523

Bristol-Myers Squibb

Foundation for Women's Cancer

Ovarian Cancer Research Alliance

FWCI

1.44

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-sa

journalhttps://doi.org/10.1016/j.celrep.2020.107884

publisherhttps://doi.org/10.1016/j.celrep.2020.107884

publisherhttps://api.elsevier.com/content/article/PII:S2211124720308652?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124720308652?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32668240

Fields of Study

Cancer-related Molecular PathwaysCancer Genomics and DiagnosticsMicrotubule and mitosis dynamicsAnimalsAntineoplastic AgentsCell DeathCell Line, TumorCyclin-Dependent KinasesCyclinsDNA Copy Number VariationsDNA DamageDNA RepairFemaleGene Expression Regulation, NeoplasticGenome, HumanHumansMice, NudeMutationNeoplasm ProteinsNeoplasmsPhenylenediaminesPoly(ADP-ribose) Polymerase InhibitorsPyrimidinesTranscription, Genetic

MeSH Terms

Poly(ADP-ribose) Polymerase InhibitorsAnimalsAntineoplastic AgentsDNA DamageDNA RepairFemaleHumansMice, NudeMutationNeoplasm ProteinsNeoplasmsPhenylenediaminesPyrimidinesTranscription, GeneticGenome, HumanGene Expression Regulation, NeoplasticCyclinsCell DeathCyclin-Dependent KinasesCell Line, TumorDNA Copy Number Variations

Keywords

Cyclin-dependent kinaseBiologyCyclin-dependent kinase 7CyclinGeneKinaseGeneticsgenomic DNAMutationHomologous recombinationDNA repairCancer researchCell cycleMolecular biologyCyclin-dependent kinase 2CancerCombination therapyParp InhibitorGenomic AlterationCdk7 Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being

Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment

FAIR Checklist

Authors (19)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)